CytoSorb(R) is Approved and Available for the Removal of Ticagrelor, a Leading Anti-Platelet Drug, During Cardiopulmonary Bypass in the E.U.

CytoSorb is the only approved therapy to remove ticagrelor in the European Union, and is intended to address a major unmet medical need of potentially life-threatening postoperative bleeding in cardiothoracic surgery patients on the drug MONMOUTH JUNCTI... Devices, Regulatory, Product Launch CytoSorbents, CytoSorb, blood purification
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news